Abstract
Ellen 't Hoen argues that one-third of the world's population lacks access to essential drugs and the new international trade rules may lead to an even worse situation in the near future. She discusses access problems related to cost, insufficient production, lack of research and development and consequences of global trade regulation and concludes that new approaches are needed to protect and further the basic human right to access to health care.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
't Hoen, E. Access to Essential Drugs and Globalization. Development 42, 87–91 (1999). https://doi.org/10.1057/palgrave.development.1110092
Published:
Issue Date:
DOI: https://doi.org/10.1057/palgrave.development.1110092